Cite
Li HY, McSharry M, Walker D, et al. Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II. Oncoimmunology. 2018;7(5):e1423182doi: 10.1080/2162402X.2017.1423182.
Li, H. Y., McSharry, M., Walker, D., Johnson, A., Kwak, J., Bullock, B., Neuwelt, A., Poczobutt, J. M., Sippel, T. R., Keith, R. L., Weiser-Evans, M. C. M., Clambey, E., & Nemenoff, R. A. (2018). Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II. Oncoimmunology, 7(5), e1423182. https://doi.org/10.1080/2162402X.2017.1423182
Li, Howard Y, et al. "Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II." Oncoimmunology vol. 7,5 (2018): e1423182. doi: https://doi.org/10.1080/2162402X.2017.1423182
Li HY, McSharry M, Walker D, Johnson A, Kwak J, Bullock B, Neuwelt A, Poczobutt JM, Sippel TR, Keith RL, Weiser-Evans MCM, Clambey E, Nemenoff RA. Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II. Oncoimmunology. 2018 Feb 13;7(5):e1423182. doi: 10.1080/2162402X.2017.1423182. eCollection 2018. PMID: 29721380; PMCID: PMC5927539.
Copy
Download .nbib